BioRender 图标

Ciliated epithelial cell 1

Ciliated epithelial cell 1 - Editable icon of Pseudostratified columnar epithelium with ciliated cells
[{"image":"https://icons.cdn.biorender.com/w75xh75/66df4773ed9462577e08bb06/5c0ad6a7c806e41200cdffe8.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66df4773ed9462577e08bb06/5c0ad6a7c806e41200cdffe8.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66df4773ed9462577e08bb07/5c0ad6a7c806e41200cdffe8.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66df4773ed9462577e08bb07/5c0ad6a7c806e41200cdffe8.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66df4773ed9462577e08bb08/5c0ad6a7c806e41200cdffe8.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66df4773ed9462577e08bb08/5c0ad6a7c806e41200cdffe8.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66df4773ed9462577e08bb09/5c0ad6a7c806e41200cdffe8.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66df4773ed9462577e08bb09/5c0ad6a7c806e41200cdffe8.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66df4773ed9462577e08bb0a/5c0ad6a7c806e41200cdffe8.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66df4773ed9462577e08bb0a/5c0ad6a7c806e41200cdffe8.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66df4773ed9462577e08bb0b/5c0ad6a7c806e41200cdffe8.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66df4773ed9462577e08bb0b/5c0ad6a7c806e41200cdffe8.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66df4773ed9462577e08bb0c/5c0ad6a7c806e41200cdffe8.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66df4773ed9462577e08bb0c/5c0ad6a7c806e41200cdffe8.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66df4773ed9462577e08bb0d/5c0ad6a7c806e41200cdffe8.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66df4773ed9462577e08bb0d/5c0ad6a7c806e41200cdffe8.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66df4773ed9462577e08bb0e/5c0ad6a7c806e41200cdffe8.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66df4773ed9462577e08bb0e/5c0ad6a7c806e41200cdffe8.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66df4773ed9462577e08bb0f/5c0ad6a7c806e41200cdffe8.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66df4773ed9462577e08bb0f/5c0ad6a7c806e41200cdffe8.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66df4773ed9462577e08bb10/5c0ad6a7c806e41200cdffe8.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66df4773ed9462577e08bb10/5c0ad6a7c806e41200cdffe8.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66df4773ed9462577e08bb11/5c0ad6a7c806e41200cdffe8.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66df4773ed9462577e08bb11/5c0ad6a7c806e41200cdffe8.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66df4773ed9462577e08bb12/5c0ad6a7c806e41200cdffe8.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66df4773ed9462577e08bb12/5c0ad6a7c806e41200cdffe8.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66df4773ed9462577e08bb13/5c0ad6a7c806e41200cdffe8.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66df4773ed9462577e08bb13/5c0ad6a7c806e41200cdffe8.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66df4773ed9462577e08bb14/5c0ad6a7c806e41200cdffe8.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66df4773ed9462577e08bb14/5c0ad6a7c806e41200cdffe8.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66df4773ed9462577e08bb15/5c0ad6a7c806e41200cdffe8.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66df4773ed9462577e08bb15/5c0ad6a7c806e41200cdffe8.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66df4773ed9462577e08bb16/5c0ad6a7c806e41200cdffe8.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66df4773ed9462577e08bb16/5c0ad6a7c806e41200cdffe8.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66df4773ed9462577e08bb17/5c0ad6a7c806e41200cdffe8.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66df4773ed9462577e08bb17/5c0ad6a7c806e41200cdffe8.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66df4773ed9462577e08bb18/5c0ad6a7c806e41200cdffe8.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66df4773ed9462577e08bb18/5c0ad6a7c806e41200cdffe8.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66df4773ed9462577e08bb19/5c0ad6a7c806e41200cdffe8.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66df4773ed9462577e08bb19/5c0ad6a7c806e41200cdffe8.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66df4773ed9462577e08bb1a/5c0ad6a7c806e41200cdffe8.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66df4773ed9462577e08bb1a/5c0ad6a7c806e41200cdffe8.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66df4773ed9462577e08bb1b/5c0ad6a7c806e41200cdffe8.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66df4773ed9462577e08bb1b/5c0ad6a7c806e41200cdffe8.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66df4773ed9462577e08bb1c/5c0ad6a7c806e41200cdffe8.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66df4773ed9462577e08bb1c/5c0ad6a7c806e41200cdffe8.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66df4773ed9462577e08bb1d/5c0ad6a7c806e41200cdffe8.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66df4773ed9462577e08bb1d/5c0ad6a7c806e41200cdffe8.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66df4773ed9462577e08bb1e/5c0ad6a7c806e41200cdffe8.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66df4773ed9462577e08bb1e/5c0ad6a7c806e41200cdffe8.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66df4773ed9462577e08bb1f/5c0ad6a7c806e41200cdffe8.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66df4773ed9462577e08bb1f/5c0ad6a7c806e41200cdffe8.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66df4773ed9462577e08bb20/5c0ad6a7c806e41200cdffe8.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66df4773ed9462577e08bb20/5c0ad6a7c806e41200cdffe8.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66df4773ed9462577e08bb21/5c0ad6a7c806e41200cdffe8.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66df4773ed9462577e08bb21/5c0ad6a7c806e41200cdffe8.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66df4773ed9462577e08bb22/5c0ad6a7c806e41200cdffe8.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66df4773ed9462577e08bb22/5c0ad6a7c806e41200cdffe8.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66df4773ed9462577e08bb23/5c0ad6a7c806e41200cdffe8.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66df4773ed9462577e08bb23/5c0ad6a7c806e41200cdffe8.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66df4773ed9462577e08bb24/5c0ad6a7c806e41200cdffe8.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66df4773ed9462577e08bb24/5c0ad6a7c806e41200cdffe8.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66df4773ed9462577e08bb25/5c0ad6a7c806e41200cdffe8.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66df4773ed9462577e08bb25/5c0ad6a7c806e41200cdffe8.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66df4773ed9462577e08bb26/5c0ad6a7c806e41200cdffe8.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66df4773ed9462577e08bb26/5c0ad6a7c806e41200cdffe8.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66df4773ed9462577e08bb27/5c0ad6a7c806e41200cdffe8.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66df4773ed9462577e08bb27/5c0ad6a7c806e41200cdffe8.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66df4773ed9462577e08bb28/5c0ad6a7c806e41200cdffe8.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66df4773ed9462577e08bb28/5c0ad6a7c806e41200cdffe8.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66df4773ed9462577e08bb29/5c0ad6a7c806e41200cdffe8.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66df4773ed9462577e08bb29/5c0ad6a7c806e41200cdffe8.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66df4773ed9462577e08bb2a/5c0ad6a7c806e41200cdffe8.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66df4773ed9462577e08bb2a/5c0ad6a7c806e41200cdffe8.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66df4773ed9462577e08bb2b/5c0ad6a7c806e41200cdffe8.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66df4773ed9462577e08bb2b/5c0ad6a7c806e41200cdffe8.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66df4773ed9462577e08bb2c/5c0ad6a7c806e41200cdffe8.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66df4773ed9462577e08bb2c/5c0ad6a7c806e41200cdffe8.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66df4773ed9462577e08bb2d/5c0ad6a7c806e41200cdffe8.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66df4773ed9462577e08bb2d/5c0ad6a7c806e41200cdffe8.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66df4773ed9462577e08bb2e/5c0ad6a7c806e41200cdffe8.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66df4773ed9462577e08bb2e/5c0ad6a7c806e41200cdffe8.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66df4773ed9462577e08bb2f/5c0ad6a7c806e41200cdffe8.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66df4773ed9462577e08bb2f/5c0ad6a7c806e41200cdffe8.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66df4773ed9462577e08bb30/5c0ad6a7c806e41200cdffe8.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66df4773ed9462577e08bb30/5c0ad6a7c806e41200cdffe8.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66df4773ed9462577e08bb31/5c0ad6a7c806e41200cdffe8.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66df4773ed9462577e08bb31/5c0ad6a7c806e41200cdffe8.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66df4773ed9462577e08bb32/5c0ad6a7c806e41200cdffe8.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66df4773ed9462577e08bb32/5c0ad6a7c806e41200cdffe8.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66df4773ed9462577e08bb33/5c0ad6a7c806e41200cdffe8.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66df4773ed9462577e08bb33/5c0ad6a7c806e41200cdffe8.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66df4773ed9462577e08bb34/5c0ad6a7c806e41200cdffe8.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66df4773ed9462577e08bb34/5c0ad6a7c806e41200cdffe8.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66df4773ed9462577e08bb35/5c0ad6a7c806e41200cdffe8.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66df4773ed9462577e08bb35/5c0ad6a7c806e41200cdffe8.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66df4773ed9462577e08bb36/5c0ad6a7c806e41200cdffe8.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66df4773ed9462577e08bb36/5c0ad6a7c806e41200cdffe8.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66df4773ed9462577e08bb37/5c0ad6a7c806e41200cdffe8.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66df4773ed9462577e08bb37/5c0ad6a7c806e41200cdffe8.png"}]
使用此图标 – 免费
注册无需信用卡。

此图标可在 BioRender 中完全编辑

  • 添加文本、形状及其他图标
  • 搜索 50,000 多种科学准确的图标
  • 重新着色并重新排列每一个图标、线条和标签
  • 导出或分享以满足任何使用需求
Scientist Avatars

加入 400 多万名科学家 的行列,制作可直接用于发表的图表

从图标到成品图表,只需几分钟

  • 搜索 来自 50,000 多个科学准确、经同行评审的图标
  • 自定义 添加标签、形状和更多图标——一切皆可完全编辑
  • 导出 或与协作者分享您的图表
    ‍

图标不合适?探索更多内容。

搜索涵盖 30 多个生命科学领域的 50,000 多个图标。

search icon
arrow-right
epithelium,columnar,epithelia,cilia,ciliated,pseudostratified epithelium,pseudostratified epithelial cell ciliated
查看更多

尝试使用同义词,或注册以在应用中请求图标。

图像类型

Ciliated epithelial cell 1 icon JPEG

Ciliated epithelial cell 1 icon PNG

Ciliated epithelial cell 1 icon SVG

Ciliated epithelial cell 1 icon GIF

BioRender 图标常见问题解答

How are scientists using the Ciliated epithelial cell 1 icon in their work?

BioRender users often use the Ciliated epithelial cell 1 icon in posters, grant applications, educational materials, and graphical abstracts. It’s especially useful for projects involving Cell Types.

我可以在 BioRender 图表或科学插图中使用此图标吗?

Yes, the Ciliated epithelial cell 1 is fully integrated into BioRender’s drag-and-drop platform. You can easily add it to any scientific figure, workflow, or poster, whether you’re building from scratch or starting with a BioRender template.

Is the Ciliated epithelial cell 1 icon customizable in BioRender?

Most icons in BioRender, including the Ciliated epithelial cell 1 icon, are customizable. You can adjust icon size, colors, and positioning, and add custom labels to tailor the design to your specific research context.

Can I export figures that include the Ciliated epithelial cell 1 icon for publication or presentations?

Yes, figures containing the Ciliated epithelial cell 1 icon can be exported in multiple formats, including PNG, JPG, PDF, and SVG. High-resolution and vector exports are available on paid plans, making them ideal for journals, slide decks, and print materials.

How do I cite BioRender if I use this icon?

Unlock publication permissions with a paid plan, and include 'Created with BioRender.com' in your figure legend, or cite BioRender directly per your journal's guidelines.

Is the Ciliated epithelial cell 1 icon used in BioRender templates or poster layouts?

Many BioRender templates include icons like the Ciliated epithelial cell 1 icon — especially those focused on Cell Types. You can search BioRender’s template library or add this icon manually to any canvas.

什么是 BioRender?

BioRender is a web‑based software that helps you create scientific figures in minutes. Use this Ciliated epithelial cell 1 icon along with our library of more than 30,000 life science icons.

在 BioRender 中使用此图标

立即开始制作专业的科学图表
antibody elements3D Phospholipid illustration

正在寻找科学内容?

浏览超过 5 万个经同行评审、易于使用且免费的图标和模板。

立即寻找您的专属素材
x icon